| Causative and susceptibility genes for Alzheimer’s disease: a review A Rocchi, S Pellegrini, G Siciliano, L Murri Brain research bulletin 61 (1), 1-24, 2003 | 466 | 2003 |
| Association between Cigarette Smoking and FHIT Gene Alterations in Lung Cancer G Sozzi, L Sard, L De Gregorio, A Marchetti, K Musso, F Buttitta, ... Cancer research 57 (11), 2121-2123, 1997 | 276 | 1997 |
| Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial P De Groot, T Nikolic, S Pellegrini, V Sordi, S Imangaliyev, E Rampanelli, ... Gut 70 (1), 92-105, 2021 | 221 | 2021 |
| p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study F Buttitta, A Marchetti, A Gadducci, S Pellegrini, M Morganti, V Carnicelli, ... British journal of cancer 75 (2), 230-235, 1997 | 201 | 1997 |
| Mind the blind brain to understand the sighted one! Is there a supramodal cortical functional architecture? E Ricciardi, D Bonino, S Pellegrini, P Pietrini Neuroscience & Biobehavioral Reviews 41, 64-77, 2014 | 193 | 2014 |
| p53 Alterations in Non-Small Cell Lung Cancers Correlate with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes A Marchetti, F Buttitta, G Merlo, F Diella, S Pellegrini, S Pepe, ... Cancer research 53 (12), 2846-2851, 1993 | 192 | 1993 |
| p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. A Marchetti, C Doglioni, M Barbareschi, F Buttitta, S Pellegrini, G Bertacca, ... Oncogene 12 (6), 1319-1324, 1996 | 182 | 1996 |
| Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin A Conte, S Pellegrini, D Tagliazucchi Brain research bulletin 62 (1), 29-38, 2003 | 176 | 2003 |
| Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study Scientific Reports 7 (1), 39471, 2017 | 153 | 2017 |
| mdm2 gene alterations and mdm2 protein expression in breast carcinomas A Marchetti, F Buttitta, S Girlando, PD Palma, S Pellegrini, P Fina, ... The Journal of pathology 175 (1), 31-38, 1995 | 152 | 1995 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 136 | 2022 |
| p53 mutations and histological type of invasive breast carcinoma A Marchetti, F Buttitta, S Pellegrini, D Campani, F Diella, D Cecchetti, ... Cancer research 53 (19), 4665-4669, 1993 | 134 | 1993 |
| BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K‐ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE A Marchetti, F Buttitta, S Pellegrini, A CHELLA, G BERTACCA, ... The Journal of pathology 179 (3), 254-259, 1996 | 131 | 1996 |
| Reduced expression of INT-6/eIF3-p48 in human tumors. A Marchetti, F Buttitta, S Pellegrini, G Bertacca, R Callahan International journal of oncology 18 (1), 175, 2001 | 125 | 2001 |
| The feeling of anger: From brain networks to linguistic expressions N Alia-Klein, G Gan, G Gilam, J Bezek, A Bruno, TF Denson, T Hendler, ... Neuroscience & Biobehavioral Reviews 108, 480-497, 2020 | 115 | 2020 |
| Genes and aggressive behavior: epigenetic mechanisms underlying individual susceptibility to aversive environments S Palumbo, V Mariotti, C Iofrida, S Pellegrini Frontiers in behavioral neuroscience 12, 117, 2018 | 105 | 2018 |
| Cyclin‐d1‐gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 … M Barbareschi, P Pelosio, O Caffo, F Buttitta, S Pellegrini, R Barbazza, ... International journal of cancer 74 (2), 171-174, 1997 | 99 | 1997 |
| Molecular genetics and antisocial behavior: where do we stand? C Iofrida, S Palumbo, S Pellegrini Experimental Biology and Medicine 239 (11), 1514-1523, 2014 | 91 | 2014 |
| mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations A Marchetti, F Buttitta, S Pellegrini, G Merlo, A Chella, CA Angeletti, ... Diagnostic Molecular Pathology 4 (2), 93-97, 1995 | 86 | 1995 |
| Expression status of candidate genes in mesothelioma tissues and cell lines O Melaiu, E Melissari, L Mutti, E Bracci, C De Santi, C Iofrida, M Di Russo, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 771, 6-12, 2015 | 85 | 2015 |
